Minerva Neurosciences, Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG00KXN3P27
NERV
Minerva Neurosciences, Inc.
GICS: -
·
Sector: Biopharmaceuticals
·
Sub-Sector: -
NAME
Minerva Neurosciences, Inc.
ISIN
US6033801068
TICKER
NERV
MIC
XNAS
REUTERS
NERV.OQ
BLOOMBERG
NERV US
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
GlobeNewswire is an important news source that provides investors with company-related information. In particular, it deals with events that may be relevant to the listing of companies or tradable financial instruments. You can access the complete overview of all reports via this link.
Tue, 05.11.2024
Minerva Neurosciences (Nasdaq: NERV) today reported business updates and financial results for the third quarter of 2024 ending September 30, 2024.
Wed, 01.05.2024
BURLINGTON, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported business updates and financial results for the first quarter of 2024 ending March 31, 2024.
Information on product placements
